|
|
|
(State or other jurisdiction of
incorporation or organization)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification No.)
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange
on which registered
|
||
|
|
The
|
Dated: June 27, 2023
|
Windtree Therapeutics, Inc.
|
||
By:
|
/s/ Craig E. Fraser
|
||
Name: Craig E. Fraser
|
|||
Title: President and Chief Executive Officer
|
Document And Entity Information |
Jun. 22, 2023 |
---|---|
Document Information [Line Items] | |
Entity, Registrant Name | Windtree Therapeutics, Inc. |
Document, Type | 8-K |
Document, Period End Date | Jun. 22, 2023 |
Entity, Incorporation, State or Country Code | DE |
Entity, File Number | 001-39290 |
Entity, Tax Identification Number | 94-3171943 |
Entity, Address, Address Line One | 2600 Kelly Road, Suite 100 |
Entity, Address, City or Town | Warrington |
Entity, Address, State or Province | PA |
Entity, Address, Postal Zip Code | 18976 |
City Area Code | 215 |
Local Phone Number | 488-9300 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock |
Trading Symbol | WINT |
Security Exchange Name | NASDAQ |
Entity, Emerging Growth Company | false |
Amendment Flag | false |
Entity, Central Index Key | 0000946486 |
-8?20$3;8T.P6BP^0"X99K>]9!:G
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end